OraSure Technologies, Inc. (NASDAQ:OSUR) Q2 2025 Earnings Call Transcript
OraSure Technologies, Inc. (NASDAQ:OSUR) Q2 2025 Earnings Call Transcript August 5, 2025OraSure Technologies, Inc. misses on earnings expectations.
Orasure Technologies Inc (OSUR)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 2,276,303 | $6,828,909 | -12% | 0.01% |
| 2. | Cannell Capital J. Carlo Cannell | 1,864,989 | $5,594,967 | +34% | 1.67% |
| 3. | D E Shaw D. E. Shaw | 1,655,266 | $4,965,798 | -5% | 0% |
| 4. | Steamboat Capital Partners Parsa Kiai | 1,593,050 | $4,779,150 | 1.36% | |
| 5. | Millennium Management Israel Englander | 1,234,356 | $3,703,068 | +3% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.08 | 12,750 | $39,270.00 | 91,524 | 2025-02-27 | Filing | |
| $3.49 | 28,670 | $100,026.76 | 1,288,334 | 2025-02-28 | Filing | |
| $3.15 | 78,625 | $247,377.84 | 1,259,664 | 2025-02-27 | Filing | |
| $3.17 | 47,659 | $151,217.24 | 70,915 | 2025-02-27 | Filing | |
| $3.15 | 64,000 | $201,683.20 | 371,013 | 2025-02-27 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.05 | 24,129 | $194,219.15 | 254,700 | 2023-12-19 | Filing | |
| $6.50 | 1,758 | $11,427.00 | 86,188 | 2023-08-15 | Filing | |
| $11.76 | 10,000 | $117,600.00 | 96,544 | 2020-12-23 | Filing | |
| $11.10 | 16,667 | $185,015.37 | 118,960 | 2019-04-01 | Filing | |
| $16.29 | 8,000 | $130,320.00 | 54,298 | 2018-08-27 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 6,568,186 | $19,704,558 | 0% | |
| 2. | 5,461,440 | $16,384,320 | 0.54% | |
| 3. | 4,252,430 | $12,757,290 | 0% | |
| 4. | 4,156,927 | $12,472,859 | 0.01% | |
| 5. | 3,837,075 | $11,511,323 | 0% |
News See All
OraSure Technologies, Inc. (NASDAQ:OSUR) Q1 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the OraSure Technologies, Inc. 2025 First Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.
OraSure Technologies, Inc. (NASDAQ:OSUR) Q4 2024 Earnings Call Transcript
OraSure Technologies, Inc. (NASDAQ:OSUR) Q4 2024 Earnings Call Transcript February 25, 2025OraSure Technologies, Inc. misses on earnings expectations.
OraSure Technologies, Inc. (NASDAQ:OSUR) Q3 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the OraSure Technologies Inc. 2024 Third Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.
8 Most Profitable Penny Stocks To Invest In
The misallocation of capital to less productive sectors can lead to inflationary pressures and hinder economic growth.
OraSure Technologies, Inc. (NASDAQ:OSUR) Q2 2024 Earnings Call Transcript
OraSure Technologies, Inc. (NASDAQ:OSUR) Q2 2024 Earnings Call Transcript August 6, 2024OraSure Technologies, Inc. misses on earnings expectations.
OraSure Technologies, Inc. (NASDAQ:OSUR) Q1 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the OraSure Technologies First Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
OraSure Technologies, Inc. (NASDAQ:OSUR) Q4 2023 Earnings Call Transcript
OraSure Technologies, Inc. beats earnings expectations. Reported EPS is $0.27, expectations were $0.13. OraSure Technologies, Inc.
OraSure Technologies, Inc. (NASDAQ:OSUR) Q3 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the OraSure Technologies Inc 2023 Third Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.
5 Best Quality Penny Stocks to Buy
Chimerix, Inc. (NASDAQ:CMRX) is working on treatments for fatal diseases. Chimerix, Inc.
Billionaire Hedge Funds
